CBD Nutraceuticals and GMP Dietary Supplements
The Nutraceutical and Food Supplement segments are the fastest growing untapped market segments for therapeutic products.
The total global nutraceuticals market reached US$ 142.1 billion in 2011 and is expected to reach US$ 204.8 billion by 2017, spurred primarily by dietary supplements and bolstered by rising health concerns, the growth of certain demographics and the increasing consumer desire to lead a healthy life and avoid dependence on synthetic drugs.
Cannabinoid-based Nutraceutical products could generate well over $1 billion annually before 2019.
The rise of this trend has seen an emergence of multi-national pharmaceutical and food companies enter the market, using Europe as a hub for commercial operations.
Creso Pharma sees Europe as the prime launching pad for its entry into the nutraceutical market. Successes in Europe should pave the way towards launches in other markets of interest, including Australia, the Middle East, the Gulf Region and Latin America.
We are committed to deliver safe, high quality CBD Nutraceutical therapeutic products by applying innovative and proprietary delivery technologies that will allow for standardisation of dose and formulation, working to full Good Manufacturing Practices for both development and manufacturing.